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Dear Editor,
W
e read with great interest the article entitled 
“are  hepatitis  B  virus  and  celiac  disease 
linked?” by Leonardi, et al, (1) published in Hepatitis 
Monthly. Celiac disease (CD), also known as gluten-
sensitive enteropathy and non-tropical sprue, is a 
prevalent  autoimmune  disorder.  The  balance  of 
evidence suggests that the celiac immunopathology 
involves  a  complex  individualized  interplay  of 
many  pathophysiological  variables  on  a  genetic 
background (2). CD develops as a consequence of 
the  encounter  between  an  environmental  trigger 
(i.e.,  derivatives  of  gluten  from  wheat,  rye,  and 
barley),  immunologic  factors,  and  a  genetically 
predisposed  host,  with  the  possible  participation 
of  other  environmental  cofactors.  In  particular, 
intestinal  infections  might  cause  a  transient  rise 
in small-bowel permeability that could lead to up-
regulation  and  release  of  tissue  transglutaminase 
which in turn, enhances gluten immunogenicity. 
Rod-shaped  bacteria  have  been  identified  in  the 
intestinal epithelium in children with CD, although 
this  colonization  could  just  be  coincidental  (3). 
Rotavirus infections could also raise the risk of CD 
in genetically predisposed children. The homology 
between the rotavirus-neutralizing protein VP-7 and 
tissue transglutaminase might explain how rotavirus 
infection is implicated in the development of CD (3). 
It has also been hypothesized that hepatitis B virus 
(HBV) and hepatitis C virus (HCV) may trigger 
immunologic gluten intolerance (4, 5). Although the 
association between CD and several liver disorders 
has long been documented, no definitive evidence 
is available about the association between HBV or 
HCV and CD. The role of HCV infection is better 
documented  and  several  studies  have  described 
the relationship between HCV infection and the 
development of CD (4). However, little data exist 
on the relationship between HBV and CD and it 
seems that no such relation is found concerning 
HBV immunization. The main finding of the study 
of Leonardi (1) is the absence of any relationship 
between CD and HBV. However, the sample size 
was  small,  the  studied  group  was  heterogeneous 
including those with ongoing and resolved HBV 
infection, there was no control group, endoscopy 
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and duodenal biopsy were not performed in patients 
who tested positive for either IgA or IgG anti-gliadin 
antibodies (Ig AGA) in whom symptoms of CD 
may be lacking. Activation of silent CD during the 
antiviral treatment with interferon-α has also been 
reported.  Nevertheless,  we  agree  with  Leonardi,   
et al, that it is not mandatory to check for specific 
CD  antibodies  before  beginning  treatment  with 
interferon and during follow-up.
In  conclusion,  we  suggest  that  the  findings  of 
this study should be open to a more conservative 
interpretation.  Therefore,  large  follow-up  studies, 
including a sample size that is more representative 
of the prevalence of CD, are needed to clarify how 
HBV  infection  may  affect  the  development  of 
this condition and to identify primary prevention 
strategies.
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